Abstract:MYC oncoprotein deregulation is a common catastrophic event in human cancer and limiting its activity restrains tumor development and maintenance, as clearly shown via Omomyc, an MYC-interfering 90 amino acid mini-protein. MYC is a multifunctional transcription factor that regulates many aspects of transcription by RNA polymerase II (RNAPII), such as transcription activation, pause release, and elongation. MYC directly associates with Protein Arginine Methyltransferase 5 (PRMT5), a protein that methylates a variety of targets, including RNAPII at the arginine residue R1810 (R1810me2s), crucial for proper transcription termination and splicing of transcripts. Therefore, we asked whether MYC controls termination as well, by affecting R1810me2S. We show that MYC overexpression strongly increases R1810me2s, while Omomyc, an MYC shRNA, or a PRMT5 inhibitor and siRNA counteract this phenomenon. Omomyc also impairs Serine 2 phosphorylation in the RNAPII carboxyterminal domain, a modification that sustains transcription elongation. ChIP-seq experiments show that Omomyc replaces MYC and reshapes RNAPII distribution, increasing occupancy at promoter and termination sites. It is unclear how this may affect gene expression. Transcriptomic analysis shows that transcripts pivotal to key signaling pathways are both up- or down-regulated by Omomyc, whereas genes directly controlled by MYC and belonging to a specific signature are strongly down-regulated. Overall, our data point to an MYC/PRMT5/RNAPII axis that controls termination via RNAPII symmetrical dimethylation and contributes to rewiring the expression of genes altered by MYC overexpression in cancer cells. It remains to be clarified which role this may have in tumor development.

C-Myc Modulates Microrna Processing Via The Transcriptional Regulation Of Drosha

Regulation of c-Myc protein stability by proteasome activator REG γ

Drosha Processing Controls the Specificity and Efficiency of Global Microrna Expression.

Profiling and Bioinformatic Analysis of Circular RNA Expression Regulated by C-Myc

Cellular Micrornas Up-Regulate Transcription Via Interaction with Promoter TATA-box Motifs

Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data

MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1∼let-7d Via Noncanonical E-box

Lin-28B Transactivation is Necessary for Myc-mediated Let-7 Repression and Proliferation

Cytoplasmic Drosha activity generated by alternative splicing

MYC Promotes Cancer Progression by Modulating M6a Modifications to Suppress Target Gene Translation

c-Myc-regulated microRNAs modulate E2F1 expression

Advance in the Regulation of c-Myc Mediated by the Ubiquitin-Proreasome Pathway

A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription Termination

p53 represses c-Myc through induction of the tumor suppressor miR-145

The Microprocessor complex mediates the genesis of microRNAs

c-Myc co-ordinates mRNA cap methylation and ribosomal RNA production

Current View of Microrna Processing

DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development

SUMOylation at K707 of DGCR8 Controls Direct Function of Primary Microrna.

The Terminal Loop Region Controls Microrna Processing by Drosha and Dicer.

Myc Represses Mir-15A/mir-16-1 Expression Through Recruitment of HDAC3 in Mantle Cell and Other Non-Hodgkin B-cell Lymphomas